HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/3/H1955    most recent 00306.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Eid, A. H. Articles by Flavahan, N. A. Search for Related Content PubMed PubMed Citation Articles by Eid, A. H. Articles by Flavahan, N. A.

Estrogen increases smooth muscle expression of _2C-adrenoceptors and cold-induced constriction of cutaneous arteries

¹Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio; ²Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and ³Faculty of Veterinary Science, University of Melbourne, Parkville, Victoria, Australia

Submitted 12 March 2007 ; accepted in final form 17 July 2007

Raynaud's phenomenon, which is characterized by intense cold-induced constriction of cutaneous arteries, is more common in women compared with men. Cold-induced constriction is mediated in part by enhanced activity of _2C-adrenoceptors (_2C-ARs) located on vascular smooth muscle cells (VSMs). Experiments were therefore performed to determine whether 17-estradiol regulates _2C-AR expression and function in cutaneous VSMs. 17-Estradiol (0.01–10 nmol/l) increased expression of the _2C-AR protein and the activity of the _2C-AR gene promoter in human cultured dermal VSMs, which was assessed following transient transfection of the cells with a promoter-reporter construct. The effect of 17-estradiol was associated with increased accumulation of cAMP and activation of the cAMP-responsive Rap2 GTP-binding protein. Transient transfection of VSMs with a dominant-negative mutant of Rap2 inhibited the 17-estradiol-induced activation of the _2C-AR gene promoter, whereas a constitutively active mutant of Rap2 increased _2C-AR promoter activity. The effects of 17-estradiol were inhibited by the estrogen receptor (ER) antagonist, ICI-182780 (1 µmol/l), and were mimicked by a cell-impermeable form of the hormone (estrogen:BSA) or by the selective ER- receptor agonist 4,4',4'''-(4-propyl-[¹H]-pyrazole-1,3,5-triyl)tris-phenol (PPT; 10 nmol/l) or the selective ER- receptor agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN; 10 nmol/l). Therefore, 17-estradiol increased expression of _2C-ARs by interacting with cell surface receptors to cause a cAMP/Rap2-dependent increase in _2C-AR transcription. In mouse tail arteries, 17-estradiol (10 nmol/l) increased _2C-AR expression and selectively increased the cold-induced amplification of ₂-AR constriction, which is mediated by _2C-ARs. An estrogen-dependent increase in expression of cold-sensitive _2C-ARs may contribute to the increased activity of cold-induced vasoconstriction under estrogen-replete conditions.

Raynaud's phenomenon; Rap1; Rap2; adenosine 3',5'-cyclic monophosphate; estrogen receptors

This article has been cited by other articles:

				A. H. Eid, M. A. Chotani, S. Mitra, T. J. Miller, and N. A. Flavahan Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle {alpha}2C-adrenoceptors Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H266 - H272. [Abstract] [Full Text] [PDF]

				J. E. Lawrence, C. A. Ray, and J. R. Carter Vestibulosympathetic reflex during the early follicular and midluteal phases of the menstrual cycle Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1046 - E1050. [Abstract] [Full Text] [PDF]